EyePoint Completes Enrollment in Phase 3 Duravyu T...
Category : Clinical Trial Update 4 August 2026EyePoint Reaches Major Clinical Development Milestone EyePoint, Inc. has announced that it has co...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Acurx Receives Positive FDA Guidance for Ibezapols...
Category : Clinical Trial Update 4 August 2026FDA Supports Continued Development of Ibezapolstat Acurx Pharmaceuticals has announced a positive...
Triquetra Health Launches BioActive Vitamin B1 Cli...
Category : Approval/Launch 4 August 2026New Supplement Combines High-Dose Benfotiamine with Essential Cofactors Triquetra Health has anno...
Chugai Files Approval Application for Enspryng in...
Category : Product Related Updates 3 August 2026Chugai Seeks New Indication for Enspryng Chugai Pharmaceutical Co., Ltd. has announced that it ha...
Atavistik Bio Joins Cure HHT Clinical Trial Networ...
Category : Clinical Trial Update 3 August 2026Atavistik Bio Expands HHT Clinical Development Efforts Atavistik Bio has announced that it has jo...
Latest Newsletter Post
-
Triquetra Health Launches BioActive..
4 August 2026
-
Acurx Receives Positive FDA Guidanc..
4 August 2026
-
EyePoint Completes Enrollment in Ph..
4 August 2026
-
Atavistik Bio Joins Cure HHT Clinic..
3 August 2026
-
Chugai Files Approval Application f..
3 August 2026
